组织金属蛋白酶抑制剂与大肠癌浸润转移的关系
摘要
基质金属蛋白酶家族是细胞外基质降解过程中的重要酶类,组织金属蛋白酶抑制剂因可抑制基质金属蛋白酶的活性而在肿瘤浸润转移中具有重要作用。
出处
《大连大学学报》
2003年第4期109-112,共4页
Journal of Dalian University
参考文献20
-
1[1]STEPHANE C, GRAEME IM. Matrix metalloproteinases in tumour. Vasion and matstasis[J]. Pathol. 1999; 189: 300-308. 被引量:1
-
2[2]BODE W, FEMANDEZ-CATALAN C, TSCHESCHE H. Insights into MMP-TIMPinteractions[J]. Cell Mol Life Sci.1999, 55(4): 639-652. 被引量:1
-
3[3]PATTERSON BC, SANG QA. Tissue inhibitor of metalloproteinases[J]. Biol Chem, 1997, 272(46): 28823-28825. 被引量:1
-
4[4]LIOTTA L. Isolation of a protein that stimulates blood vessel growth[J]. Nature, 1985, 318(6041): 14. 被引量:1
-
5[5]HOFMANN UB, WESTPHAL JR, VANKRAATS AA, et al. Expression of integrin alpha(v) beta(3) correlates with activation of membrane-type matrix metalloproteinase-1(MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo[J]. Int J Cancer, 2000, 87(1): 12-19. 被引量:1
-
6[6]KLEINER DJ, TUUTTILA, TRYGGVASON K, et al. Stability analysis of latent and active 72kDa type IV collagenese:the role of tissue inhibitor of metalloproteinase-2(TIMP-2)[J]. Bio, 1993; 32: 1583. 被引量:1
-
7[7]LOTZ M, GUERNE PA. Interleukin- 6 induces the synthesis of tissue inhibitor of metaloproteinase- 1 (TIMP-1)/enythoid potentiating activity[ J ]. Biol Chem, 1991; 266: 11563. 被引量:1
-
8[8]RAO VN, CHAUDHRY V, MANSILLA-SOTO J, ZENG ZS, SHU WP, GUILLEM JG. Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo[J]. Clinical & experimental metastasis. 1999,17(4): 341-349. 被引量:1
-
9[9]FAN S, BERGIN FG, LEAPER DJ. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging[J].British journal of surgery. 2000, 87(9): 1215-1221. 被引量:1
-
10[10]GUI JQ, HAN SY, LEE MS, KIM HR, BAEK SH, AHN DH, CHAE HS. Erickson Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells[J]. International Journal of Oncology. 2000, 17(3): 487-494. 被引量:1
二级参考文献22
-
1Maquoi E;FrankenneF;BaramovaE.Membrane type 1 matrix metalloproteinase- associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines[J],2000(15). 被引量:1
-
2Garbett EA;ReedMW;BrownNJ.Proteolysis in human breast and colorectal cancer,1999(02). 被引量:1
-
3Schwingshackl A;Duszyk M;Brown N.Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha[J],1999(05). 被引量:1
-
4Michael M;Babic B;Khokha R.Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer[J],1999(06). 被引量:1
-
5Ohtani H;Tabata N;Nagura H.Immunoelectron microscopic localization of gelatinase A in human gastrointestinal and skin carcinomas:difference between cancer cells and fibroblasts,1995(03). 被引量:1
-
6Tokumaru Y;Fujii M;Otani Y.Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma:studies of clinical sarples and in vitro cell lines co-cultured with fibroblasts,2000(01). 被引量:1
-
7Liotta L.Isolaton of a protein that stimulates blood vessel growth[J],1985(6041). 被引量:1
-
8Powell WC;Knox JD;Navre M.Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice,1993(02). 被引量:1
-
9Hofmann UB;Westphal JR;Van Kraats AA.Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2(MMP-2) in human melanoma cells in vitro and in vivo[J],2000(01). 被引量:1
-
10Imren S;Kohn DB;Shimada H.Overexpression of tissue inhibitor of metalloproteinases-2 retrovirl-mediated gene transfer in vivo inhibits tumor growth and invasion,1996(13). 被引量:1
共引文献68
-
1李琦,李湘平,姚连生.基质金属蛋白酶-2,9在下咽癌中的表达及其与淋巴结转移的相关性[J].临床耳鼻咽喉科杂志,2004,18(6):324-326. 被引量:5
-
2赵力群,司书毅.基质金属蛋白酶抑制剂研究进展[J].中国新药杂志,2004,13(6):494-498. 被引量:6
-
3李海刚,吕志强,李劲松,谢德荣,沈溪明.舌鳞癌MMPs和COX-2的表达及其相互关系[J].中国肿瘤,2004,13(9):576-578. 被引量:2
-
4张琳,王飞,李海涛.基质金属蛋白酶抑制剂的抗肿瘤作用研究[J].解放军药学学报,2004,20(4):262-264. 被引量:1
-
5李琦,李湘平,梁勇,刘雄.下咽癌中基质金属蛋白酶-2的表达及其临床意义[J].第一军医大学学报,2003,23(5):495-497. 被引量:2
-
6张惠忠,吕志强,谢德荣,李海刚,熊利华,张华,陈晓兵.COX-2和MMP-2蛋白的表达对肺癌预后的影响[J].癌症,2004,23(10):1190-1193. 被引量:1
-
7李劲松,李海刚,蔡华雄,段朝晖,沈溪明,何璇凌.明胶酶在舌鳞癌发生、演进中的表达和意义[J].中山大学学报(医学科学版),2005,26(1):109-111. 被引量:5
-
8何旭,张丽红,许传杰,王阳,朱桂彬,张海英,李玉林.基质金属蛋白酶-2与乳腺癌血管生成和肿瘤生物学行为的关系[J].中国临床康复,2005,9(2):155-157.
-
9吴四海,乔宗海,顾晓峰,马俭.MMP-9及CD147在下咽癌中的表达及其临床意义[J].江苏医药,2005,31(3):170-172. 被引量:2
-
10张慧芹,刘阁玲.基质金属蛋白酶-9在甲状腺癌中的表达及临床意义[J].医学理论与实践,2005,18(4):389-390. 被引量:14
-
1牟英君,刘凯,齐云飞.恶性外周神经鞘膜瘤中基质金属蛋白酶-9及其组织金属蛋白酶抑制剂的表达与临床病理和预后的相关性研究[J].菏泽医学专科学校学报,2008,20(1):1-4.
-
2张彪,陈仙.MMPs、TIMPs与膀胱癌侵袭和转移的研究进展[J].社区医学杂志,2011,9(4):33-35. 被引量:3
-
3郭静(综述),王晓文,唐劲天(审校).基质金属蛋白酶与肿瘤微环境的关系[J].国际肿瘤学杂志,2008,35(11):810-812. 被引量:1
-
4康旭,王芳,曹军,冼沛中.MMP-9、TIMP-1及VEGF在大肠癌中的表达与临床病理和预后的相关性研究[J].中国实验诊断学,2005,9(4):546-548. 被引量:5
-
5李颖,江昌新.MMPs和TIMPs与甲状腺癌[J].国外医学(内分泌学分册),2005,25(B04):56-58. 被引量:1
-
6温洪涛,张蕾,李继昌.食管鳞癌组织中TIMP的表达[J].肿瘤基础与临床,2006,19(4):265-266. 被引量:1
-
7姜学东,孟庆显,陈东义,樊红伟,古力.MMP-9和TIMP-1在非小细胞肺癌中的表达及临床意义[J].武警医学,2002,13(2):67-69. 被引量:2
-
8万远廉,魏群,潘义生,刘玉村.基质金属蛋白酶和组织金属蛋白酶抑制剂在大肠癌中的表达[J].中华外科杂志,2000,38(7):510-513. 被引量:5
-
9李洪涛,宁连胜,张斌,王金科,牛昀,高宇.利用组织芯片方法探讨乳腺癌组织中TIMP-1 TIMP-2表达及预后意义[J].中国肿瘤临床,2007,34(3):132-135. 被引量:2
-
10杜云毅(综述),戴冬秋(审校).新型抑癌基因RECK[J].国际肿瘤学杂志,2009,36(5):323-326.